Pictet Asset Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2M | Buy |
1,175,661
+124,983
| +12% | +$4.06M | 0.04% | 363 |
|
|
2025
Q1 | $42.2M | Buy |
1,050,678
+32,833
| +3% | +$1.32M | 0.05% | 341 |
|
|
2024
Q4 | $83.3M | Buy |
1,017,845
+236,940
| +30% | +$19.4M | 0.09% | 229 |
|
|
2024
Q3 | $89.2M | Buy |
780,905
+248,001
| +47% | +$28.3M | 0.1% | 212 |
|
|
2024
Q2 | $40.2M | Sell |
532,904
-328,665
| -38% | -$24.8M | 0.05% | 321 |
|
|
2024
Q1 | $58.9M | Sell |
861,569
-287,640
| -25% | -$19.6M | 0.06% | 281 |
|
|
2023
Q4 | $72.2M | Sell |
1,149,209
-325,573
| -22% | -$20.4M | 0.08% | 248 |
|
|
2023
Q3 | $75.2M | Buy |
+1,474,782
| New | +$75.2M | 0.09% | 226 |
|